Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy
The DOI matches its Crossref record; 336 of the 341 references it cites were found in a registry or an index.
Abstract
Cigarette smoking during pregnancy is the single largest modifiable risk for pregnancy-related morbidity and mortality in the US. Addiction to nicotine prevents many pregnant women who wish to quit smoking from doing so. The safety and efficacy of nicotine replacement therapy (NRT) for smoking cessation during pregnancy have not been well studied. Nicotine is classified by the US Food and Drug Administration as a Pregnancy Category D drug. Animal studies indicate that nicotine adversely affects the developing fetal CNS, and nicotine effects on the brain may be involved in the pathophysiology of sudden infant death syndrome (SIDS). It has been assumed that the cardiovascular effects of nicotine resulting in reduced blood flow to the placenta (uteroplacental insufficiency) is the predominant mechanism of the reproductive toxicity of cigarette smoking during pregnancy. Short term high doses of nicotine in pregnant animals do adversely affect the maternal and fetal cardiovascular systems. However, studies of the acute effects of NRT in pregnant humans indicate that nicotine alone has minimal effects upon the maternal and fetal cardiovascular systems. Cigarette smoking delivers thousands of chemicals, some of which are well documented reproductive toxins (e.g. carbon monoxide and lead). A myriad of cellular and molecular biological abnormalities have been documented in placentas, fetuses, and newborns of pregnant women who smoke. The cumulative abnormalities produced by the variou…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a strong theoretical rationale for using NRT to avoid smoking in pregnancy; even if women do not stop smoking completely, cigarette smoke exposes the fetus to numerous toxins whereas NRT exposes them to only nicotine, and so is very likely to be safer [15].”
From Fetal safety of nicotine replacement therapy in pregnancy: systematic review and meta-analysis. (2021) · cites this paper as [15]
In the citing paper
“Similar reviews have had less thorough search strategies, presented only narrative data or have not attempted to assess bias [15,58,59].”
From Fetal safety of nicotine replacement therapy in pregnancy: systematic review and meta-analysis. (2021) · cites this paper as [15]
In the citing paper
“Vaping has the advantage that it does not involve tobacco combustion, which is the primary source of harm from smoking cigarettes [7, 17].”
From Vaping during pregnancy: a systematic review of health outcomes. (2024) · cites this paper as [17]
Citations
Cites
Carbon Monoxide: a Putative Neural Messenger
Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V., & Snyder, S. H. (1993) · Science · doi:10.1126/science.7678352 · Cited by 1,563
Celermajer, D. S., Sorensen, K. E., Georgakopoulos, D., Bull, C., Thomas, O., Robinson, J., & Deanfield, J. E. (1993) · Circulation · doi:10.1161/01.cir.88.5.2149 · Cited by 1,533
(1989) · Pediatric Research · doi:10.1203/00006450-198902000-00010 · Cited by 879
Fetal Nicotine or Cocaine Exposure: Which One is Worse?
Slotkin, T. A. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37495-6 · Cited by 676
Pharmacology of Nicotine: Addiction and Therapeutics
Benowitz, N. L. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.003121 · Cited by 589 · cited 3×
“Addiction to nicotine prevents many pregnant women who wish to quit from doing so.[3] Nicotine replacement therapy (NRT) in nonpregnant adults increases quit rates when used as adjunctive therapy in a smoking cessation programme.”
BackgroundSelf-citationThe maternal and fetal physiologic effects of nicotine
Lambers, D. S., & Clark, K. E. (1996) · Seminars in Perinatology · doi:10.1016/s0146-0005(96)80079-6 · Cited by 575
The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant
Longo, L. D. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90824-9 · Cited by 485
Hoffmann, D., Djordjevic, M. V., & Hoffmann, I. (1997) · Preventive Medicine · doi:10.1006/pmed.1997.0183 · Cited by 421
Gadek, J. E., Fells, G. A., & Crystal, R. G. (1979) · Science · doi:10.1126/science.316188 · Cited by 401
The influence of smoking on vitamin C status in adults.
Schectman, G., Byrd, J. C., & Gruchow, H. W. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.2.158 · Cited by 341
Research works printed but not linked: 61
- Adams, 1997, MMWR Morbid Mort Wkly Rep, 46, 1048
- Dempsey, 1998, Clin Pharmacol Ther, 63, 202
- Lindblad, 1988, Obstet Gynecol, 72, 371
- Craigo, 1994, Sem Perinatal, 18, 292
- Eriksen, 1983, Obstet Gynecol, 61, 367
- Bruner, 1991, J Reprod Med, 36, 435
- Castro, 1993, Obstet Gynecol, 81, 551
- Barrett, 1981, Obstet Gynecol, 57, 422
- Huisman, 1997, J Reprod Med, 42, 731
- Kirschbaum, 1970, Obstet Gynecol, 35, 527
- Manning, 1978, Obstet Gynecol, 52, 563
- Nash, 1988, Histol Histopathol, 3, 377
- Sheina, 1983, Farmakol Toksikol, 46, 93
- Leichter, 1989, Growth Dev Aging, 53, 129
- Leichter, 1995, Growth Dev Aging, 59, 63
- Bertolini, 1982, Neurobehav Toxicol Teratol, 4, 545
- Peters, 1979, Neurobehav Toxicol, 1, 221
- Martin, 1981, Neurobehav Toxicol Teratol, 3, 261
- Peters, 1982, Arch Int Pharmacodyn Ther, 257, 155
- Martin, 1982, Neurobehav Toxicol Teratol, 4, 293
- Johns, 1982, Neurobehav Toxicol Teratol, 4, 365
- Peters, 1984, Res Commun Chem Pathol Pharmacol, 46, 307
- Slotkin, 1987, J Pharmacol Exp Ther, 240, 602
- Slotkin, 1987, J Pharmacol Exp Ther, 242, 232
- Navarro, 1988, J Pharmacol Exp Ther, 244, 940
- Ribary, 1989, J Pharmacol Exp Ther, 248, 786
- Navarro, 1989, J Pharmacol Exp Ther, 251, 894
- Britos, 1992, Acta Physiol Pharmacol Ther Latinoam, 42, 217
- Slotkin, 1997, Teratology, 55, 177, 10.1002/(SICI)1096-9926(199703)55:3<177::AID-TERA2>3.0.CO;2-# · DOI · Paper page
- Poland, 1996, Neurotoxicology, 17, 351
- Paulson, 1991, J Craniofac Genet Dev Biol, 11, 48
- Paulson, 1994, J Craniofac Genet Dev Biol, 14, 16
- Leblebicioglu-Bekcioglu, 1995, J Craniofac Genet Dev Biol, 15, 146
- Nash, 1989, Anat Anz, 168, 109
- Daeninck, 1991, Anat Anz, 172, 257
- Saad, 1990, Biol Struct Morphog, 3, 31
- Saad, 1991, Acta Morphol Hung, 39, 87
- Gartner, 1990, J Biol Buccale, 18, 83
- Lee, 1981, Obstet Gynecol, 57, 220
- Anand, 1996, Biochem Mol Biol Int, 38, 21
- Pasanen, 1985, Biol Res Pregnancy Perinatol, 6, 94
- Busacca, 1986, Obstet Gynecol, 68, 816
- Ylikorkala, 1985, Obstet Gynecol, 66, 102
- Ylikorkala, 1988, Obstet Gynecol, 71, 61
- Boomer, 1982, J Reprod Med, 27, 385
- Shiono, 1986, JAMA, 255, 82, 10.1001/jama.1986.03370010088030 · DOI · Paper page
- Burns, 1994, J Acquir Immunol Def Syndrome, 7, 718
- Fisher, 1982, J Reticuloendothel Soc, 32, 311
- Anderson, 1979, S Afr Med J, 56, 401
- Casanueva, 1991, Eur J Clin Nutr, 45, 401
- Chatterjee, 1988, J Reprod Med, 33, 417
- Lagerkvist, 1992, IARC Sci Publ, 287-, 91
- Kuhnert, 1988, Obstet Gynecol, 71, 67
- Norman, 1990, Ann Occup Hyg, 34, 335
- Carratu, 1993, Soc Neurosci, 19, 834
- Singh, 1986, Neurotoxicology, 7, 475
- Fechter, 1976, Adverse Effects Environ Chem Psychotropic Drugs, 2, 219
- Fechter, 1980, Neurobehav Toxicol, 2, 7
- Penney, 1983, Am J Physiol, 244, H289
- Penney, 1987, Growth, 51, 321
- Daughton, 1991, Arch Int Med, 151, 749, 10.1001/archinte.1991.00400040091020 · doi:10.1001/archinte.1991.00400040091020
Cited by
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,321
“Nicotine crosses the placental barrier easily, and there is evidence for the accumulation of nicotine in fetal serum and amnionic fluid in slightly higher concentrations than in maternal serum (Luck et al., 1985; Pastrakuljic et al., 1998; Dempsey and Benowitz, 2001).”
BackgroundSelf-citationNicotine Chemistry, Metabolism, Kinetics and Biomarkers
Benowitz, N. L., Hukkanen, J., & Jacob, P. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_2 · Cited by 1,179
“Nicotine crosses the placental barrier easily, and there is evidence for accumulation of nicotine in fetal serum and amnionic fluid in slightly higher concentrations than in maternal serum (Dempsey and Benowitz 2001).”
BackgroundSelf-citationInterventions for promoting smoking cessation during pregnancy
Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., & Watson, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub3 · Cited by 890
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Oliver, S., Chamberlain, C., & Oakley, L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub2 · Cited by 622
Siu, A. L., & for the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-2023 · Cited by 515
“However, it has been suggested that NRT may be safer than smoking during pregnancy (4, 11).”
Background
Metadata
- Authors
- Dempsey, D. A., & Benowitz, N. L.
- Affiliations
- University of California, San Francisco (US)
- San Francisco General Hospital (US)
- Corresponding author
- Benowitz, Neal L.
- ORCID
- Benowitz, Neal L.
- Venue
- Drug Safety
- Published
- 2001
- Volume
- 24
- Issue
- 4
- Pages
- 277-322
- ISSN
- 0114-5916 (ISSN-L)
- OpenAlex
- W2078936977
- Cited by
- 346
- References
- 341
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 14 · 2023: 5 · 2022: 11 · 2021: 13 · 2020: 15 · 2019: 17 · 2018: 9 · 2017: 10 · 2016: 16 · 2015: 12 · 2014: 17 · 2013: 7 · 2012: 19
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA02277, DA 12393, P30DA012393)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- nicotine replacement therapy, smoking cessation during pregnancy, smoking during pregnancy, placental insufficiency, sudden infant death syndrome, placental abruption, breastfeeding, reproductive toxicity, pregnancy registry
- MeSH terms
- Animals, Disease Models, Animal, Female, Fetus, Humans, Nicotine, Pregnancy, Pregnancy Complications, Smoking Cessation, Risk Assessment, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy. https://app.cochat.ai/papers/10.2165/00002018-200124040-00005
- The paper
- Dempsey, D. A., & Benowitz, N. L. (2001). Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy. Drug Safety. https://doi.org/10.2165/00002018-200124040-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.